PRECIPIO, INC. (PRPO) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 3.70M USD | Liabilities, Current |
| Cash and equivalents | 3.08M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 2.28M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 776.00K USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $3.70M | $3.08M | (m) | $2.28M | $776.00K | (m) |
| 2026-03-31 | (m) | $3.81M | $2.60M | (m) | $1.99M | $870.00K | (m) |
| 2025-12-31 | (m) | $3.75M | $2.65M | (m) | $1.98M | $935.00K | (m) |
| 2025-09-30 | (m) | $4.45M | $2.31M | (m) | $1.96M | $788.00K | (m) |
| 2025-06-30 | (m) | $4.35M | $1.13M | (m) | $1.49M | $1.06M | (m) |
| 2025-03-31 | (m) | $4.33M | $1.02M | (m) | $976.00K | $825.00K | (m) |
| 2024-12-31 | (m) | $4.27M | $1.39M | (m) | $799.00K | $724.00K | (m) |
| 2024-09-30 | (m) | $4.48M | $1.05M | (m) | $1.02M | $590.00K | (m) |
| 2024-06-30 | (m) | $4.59M | $1.28M | (m) | $1.11M | $653.00K | (m) |
| 2024-03-31 | (m) | $3.33M | $776.00K | (m) | $906.00K | $532.00K | (m) |
| 2023-12-31 | (m) | $3.14M | $1.50M | (m) | $1.30M | $384.00K | (m) |
| 2023-09-30 | (m) | $5.45M | $1.56M | (m) | $1.48M | $636.00K | (m) |
| 2023-06-30 | (m) | $4.72M | $2.57M | (m) | $884.00K | $537.00K | (m) |
| 2023-03-31 | (m) | $4.50M | $2.14M | (m) | $858.00K | $546.00K | (m) |
| 2022-12-31 | (m) | $4.36M | $3.44M | (m) | $1.04M | $708.00K | (m) |
| 2022-09-30 | (m) | $4.41M | $5.14M | (m) | $955.00K | $663.00K | (m) |
| 2022-06-30 | (m) | $4.39M | $7.47M | (m) | $1.13M | $642.00K | (m) |
| 2022-03-31 | (m) | $4.39M | $9.26M | (m) | $1.15M | $522.00K | (m) |
| 2021-12-31 | (m) | $4.21M | $11.67M | (m) | $697.00K | $564.00K | (m) |
| 2021-09-30 | (m) | $3.65M | $13.22M | (m) | $570.00K | $680.00K | (m) |
| 2021-06-30 | (m) | $3.64M | $15.70M | (m) | $443.00K | $556.00K | (m) |
| 2021-03-31 | (m) | $4.18M | $2.29M | (m) | $625.00K | $472.00K | (m) |
| 2020-12-31 | (m) | $4.66M | $2.66M | (m) | $874.00K | $350.00K | (m) |
| 2020-09-30 | (m) | $4.47M | $2.16M | (m) | $1.09M | $280.00K | (m) |
| 2020-06-30 | (m) | $4.68M | $353.00K | (m) | $1.35M | $233.00K | (m) |
| 2020-03-31 | (m) | $6.74M | $417.00K | (m) | $883.00K | $195.00K | (m) |
| 2019-12-31 | (m) | $4.33M | $848.00K | (m) | $574.00K | $184.00K | (m) |
| 2019-09-30 | (m) | $4.64M | $1.68M | (m) | $693.00K | $182.00K | (m) |
| 2019-06-30 | (m) | $4.75M | $1.17M | (m) | $883.00K | $189.00K | (m) |
| 2019-03-31 | (m) | $9.95M | $302.00K | (m) | $801.00K | $149.00K | (m) |
| 2018-12-31 | (m) | $13.77M | $381.00K | (m) | $690.00K | $197.00K | (m) |
| 2018-09-30 | (m) | $10.29M | $219.00K | (m) | $658.00K | $175.00K | (m) |
| 2018-06-30 | (m) | $9.28M | $71.00K | (m) | $752.00K | $171.00K | (m) |
| 2018-03-31 | (m) | $8.75M | $286.00K | (m) | $552.00K | $159.00K | (m) |
| 2017-12-31 | (m) | $10.04M | $421.00K | (m) | $730.00K | $161.00K | (m) |
| 2017-09-30 | (m) | $13.73M | $381.00K | (m) | $505.00K | $99.00K | (m) |
| 2017-06-30 | (m) | $16.31M | $967.00K | (m) | $569.00K | $108.00K | (m) |
| 2017-03-31 | (m) | $21.13M | $59.00K | (m) | $279.00K | $15.00K | (m) |
| 2016-12-31 | (m) | $19.82M | $110.00K | (m) | $225.00K | $24.00K | (m) |
| 2016-09-30 | (m) | $18.26M | $71.00K | (m) | $180.00K | $36.00K | (m) |
| 2016-06-30 | (m) | $17.72M | $421.00K | (m) | $328.00K | $39.00K | (m) |
| 2016-03-31 | (m) | $17.28M | $222.00K | (m) | $170.00K | $44.00K | (m) |
| 2015-12-31 | (m) | $16.98M | $444.00K | (m) | $264.00K | $50.00K | (m) |
| 2015-09-30 | (m) | $16.15M | $2.79M | (m) | $9.25M | (m) | (m) |
| 2015-06-30 | (m) | $13.31M | $2.31M | (m) | $9.72M | $2.62M | (m) |
| 2015-03-31 | (m) | $11.07M | $5.38M | (m) | $8.35M | $2.98M | (m) |
| 2014-12-31 | (m) | $11.12M | $1.61M | (m) | $7.63M | $3.00M | (m) |
| 2014-09-30 | (m) | $9.81M | $880.00K | (m) | $7.51M | $3.59M | (m) |
| 2014-06-30 | (m) | $9.76M | $1.19M | (m) | $7.30M | $4.01M | (m) |
| 2014-03-31 | (m) | $8.05M | $1.74M | (m) | $6.19M | $4.05M | (m) |
| 2013-12-31 | (m) | $8.63M | $1.63M | (m) | $5.31M | $3.96M | (m) |
| 2013-09-30 | (m) | $8.99M | $4.02M | (m) | $4.41M | $4.45M | (m) |
| 2013-06-30 | (m) | $7.91M | $6.39M | (m) | $8.04M | $4.41M | (m) |
| 2013-03-31 | (m) | $9.49M | $7.73M | (m) | $7.90M | $4.78M | (m) |
| 2012-12-31 | (m) | $16.53M | $4.50M | (m) | $8.08M | $5.09M | (m) |
| 2012-09-30 | (m) | $16.60M | $4.75M | (m) | $8.16M | $4.41M | (m) |
| 2012-06-30 | (m) | $14.77M | $6.30M | (m) | $8.62M | $4.03M | (m) |
| 2012-03-31 | (m) | $15.62M | $19.29M | (m) | $6.70M | $4.01M | (m) |
| 2011-12-31 | (m) | $16.33M | $4.95M | (m) | $7.57M | $3.86M | (m) |
| 2011-09-30 | (m) | $10.10M | $1.42M | (m) | $7.59M | $3.31M | (m) |
| 2011-06-30 | (m) | $9.90M | $2.64M | (m) | $7.19M | $3.31M | (m) |
| 2010-12-31 | (m) | $8.25M | $3.45M | (m) | $7.60M | $3.34M | (m) |
| 2010-09-30 | (m) | (m) | $4.59M | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | $5.42M | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | (m) | $5.64M | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | (m) | $4.77M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |